A non-purine selective xanthine oxidase inhibitor used for the chronic management of hyperuricemia in adult patients with gout. Lowers serum uric acid by blocking its production, supporting long-term urate control and reducing gout flares.
Applications and dosage forms. Febuxostat API is used in 40 mg and 80 mg film-coated tablets for the long-term management of hyperuricemia in gout. Reine Lifescience supplies a grade suited to these formulations; confirm the required particle size and specification at enquiry.
Quality, documentation and supply. Febuxostat is manufactured under Reine's in-house specification, aligned to the key pharmacopoeial and ICH expectations for assay, related substances and residual solvents. Reine provides CoA, specification, method of analysis, SDS and stability data to support ANDA, dossier and tender submissions in regulated and semi-regulated markets.

| CAS Number | Pharmacopoeia | DMF | CEP | MFDS | ANVISA | EDMF |
|---|---|---|---|---|---|---|
| 144060-53-7 | IH | ✓ Yes | — | — | — | — |
Also known as: Febuxostat API · Febuxostat manufacturer India
The CAS number of Febuxostat is 144060-53-7.
Reine Lifescience supplies Febuxostat in in-house (IH) specification.
Fill the enquiry form on this page, or contact Reine Lifescience with the product name, grade and required quantity.
Febuxostat is an oral, non-purine selective xanthine oxidase inhibitor used for the chronic management of hyperuricemia in adult patients with gout.
Febuxostat (CAS 144060-53-7) has the molecular formula C16H16N2O3S and a molecular weight of approximately 316.4 g/mol.
Febuxostat API is used in film-coated tablets of 40 mg and 80 mg. Reine Lifescience supplies a grade suitable for these formulations; confirm the required particle size and specification at enquiry.
Reine Lifescience provides a Certificate of Analysis, specification sheet, method of analysis, Safety Data Sheet (SDS) and stability data with every supply. Additional regulatory documentation for registration in your market is available on request.
Yes. Reine Lifescience exports APIs to pharmaceutical partners in 45+ countries from its WHO-GMP certified facility in Ankleshwar, Gujarat, India. Share your country, quantity and required grade of Febuxostat and the international sales team will respond within 24 hours with pricing, lead time and documentation.